Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats
| Autor: | Gomaa, Adel A., Farghaly, Hanan S.M., Ahmed, Asmaa M., Hemida, Fahmy K. |
|---|---|
| Zdroj: | In International Immunopharmacology April 2023 117 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect